Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
SpineGuard S.A. specializes in the global design, development, and commercialization of advanced medical instruments for surgical procedures. Their product line includes various PediGuard probes: the Straight probe for precise screw placement; the Curved probe, featuring a tapered tip to facilitate easier pedicle penetration; and the Cannulated probe, engineered to help surgeons minimize radiation exposure during minimally-invasive operations. They also offer the PediGuard Threaded Device, a specialized drilling tool. Complementing these devices, SpineGuard provides the DSG (Dynamic Surgical Guidance) Connect app, which collects and visualizes real-time signals from DSG-enabled instruments during pedicle drilling, alongside the DSG smart screw for streamlined one-step screw insertion. SpineGuard's innovative solutions serve a broad spectrum of healthcare stakeholders, including patients, surgeons, operating room staff, and other healthcare providers. Founded in 2009, the company is headquartered in Vincennes, France.
Company Valuation
From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks.